412 related articles for article (PubMed ID: 24177357)
1. Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring.
Chinthala Y; Kumar Domatti A; Sarfaraz A; Singh SP; Kumar Arigari N; Gupta N; Satya SK; Kotesh Kumar J; Khan F; Tiwari AK; Paramjit G
Eur J Med Chem; 2013; 70():308-14. PubMed ID: 24177357
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives.
Barakat A; Islam MS; Al-Majid AM; Ghabbour HA; Fun HK; Javed K; Imad R; Yousuf S; Choudhary MI; Wadood A
Bioorg Med Chem; 2015 Oct; 23(20):6740-8. PubMed ID: 26381063
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative activity of 8-hydroxyquinoline derivatives containing a 1,2,3-triazole moiety.
Freitas LB; Borgati TF; de Freitas RP; Ruiz AL; Marchetti GM; de Carvalho JE; da Cunha EF; Ramalho TC; Alves RB
Eur J Med Chem; 2014 Sep; 84():595-604. PubMed ID: 25062010
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
[TBL] [Abstract][Full Text] [Related]
10. Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies.
Rostom SAF; Badr MH; Abd El Razik HA; Ashour HMA
Eur J Med Chem; 2017 Oct; 139():263-279. PubMed ID: 28803043
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity.
Chinthala Y; Thakur S; Tirunagari S; Chinde S; Domatti AK; Arigari NK; K V N S S; Alam S; Jonnala KK; Khan F; Tiwari A; Grover P
Eur J Med Chem; 2015 Mar; 93():564-73. PubMed ID: 25743216
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of anticancer and antiobesity activity of 1-ethoxy carbonyl-3,5-bis (3'-indolyl methylene)-4-pyperidone analogs.
Buduma K; Chinde S; Dommati AK; Sharma P; Shukla A; Srinivas KVNS; Arigari NK; Khan F; Tiwari AK; Grover P; Jonnala KK
Bioorg Med Chem Lett; 2016 Mar; 26(6):1633-1638. PubMed ID: 26873414
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
Kumar K; Sagar S; Esau L; Kaur M; Kumar V
Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological activity, and molecular modeling studies of 1H-1,2,3-triazole derivatives of carbohydrates as alpha-glucosidases inhibitors.
Ferreira SB; Sodero AC; Cardoso MF; Lima ES; Kaiser CR; Silva FP; Ferreira VF
J Med Chem; 2010 Mar; 53(6):2364-75. PubMed ID: 20170190
[TBL] [Abstract][Full Text] [Related]
16. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivo.
Wang XM; Xu J; Li YP; Li H; Jiang CS; Yang GD; Lu SM; Zhang SQ
Eur J Med Chem; 2013 Sep; 67():243-51. PubMed ID: 23871904
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group.
Chen PC; Patil V; Guerrant W; Green P; Oyelere AK
Bioorg Med Chem; 2008 May; 16(9):4839-53. PubMed ID: 18397827
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives.
Patil V; Tilekar K; Mehendale-Munj S; Mohan R; Ramaa CS
Eur J Med Chem; 2010 Oct; 45(10):4539-44. PubMed ID: 20667627
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxic activities of novel hybrid 2-phenyl-3-alkylbenzofuran and imidazole/triazole compounds.
Chen W; Deng XY; Li Y; Yang LJ; Wan WC; Wang XQ; Zhang HB; Yang XD
Bioorg Med Chem Lett; 2013 Aug; 23(15):4297-302. PubMed ID: 23800685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
